Coutts; Stephen M.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Coutts; Stephen M..The latest application filed is for "ascorbic acid, quinone compound, and sodium glucose cotransporter inhibitor for treating cancer".

Company Profile

0.6.9

Coutts; Stephen M. - Santa Fe NM
COUTTS; Stephen M. - San Diego CA
Coutts; Stephen M. - Rancho Santa Fe CA
Coutts, Stephen M. - Rancho Sante Fe CA
Coutts; Stephen M. - Scarsdale NY

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Ascorbic Acid, Quinone Compound, And Sodium Glucose Cotransporter Inhibitor For Treating Cancer App 20210283100 - Miller; Thomas M. ; et al.	2021-09-16
Chemically-defined Non-polymeric Valency Platform Molecules And Conjugates Thereof App 20080293660 - COUTTS; Stephen M. ; et al.	2008-11-27
Chemically defined non-polymeric valency platform molecules and conjugates thereof Grant 7,351,855 - Coutts , et al. April 1, 2	2008-04-01
Chemically-defined non-polymeric valency platform molecules and conjugates thereof App 20070254851 - Coutts; Stephen M. ; et al.	2007-11-01
Chemically-defined non-polymeric valency platform molecules and conjugates thereof Grant 7,115,581 - Coutts , et al. October 3, 2	2006-10-03
Composition for inducing humoral anergy to an immunogen comprising a T cell epitope-deficient analog of the immunogen conjugated to a nonimmunogenic valency platform molecule App 20050031635 - Coutts, Stephen M. ; et al.	2005-02-10
Chemically defined non-polymeric valency platvorm molecules and conjugates thereof App 20050026856 - Coutts, Stephen M. ; et al.	2005-02-03
Chemically-defined non-polymeric valency platform molecules and conjugates thereof App 20030162953 - Coutts, Stephen M. ; et al.	2003-08-28
Composition for inducing humoral anergy to an immunogen comprising a T cell epitope-deficient analog of the immunogen conjugated to a nonimmunogenic valency platform molecule App 20030103990 - Coutts, Stephen M. ; et al.	2003-06-05
Conjugates of chemically defined non-polymeric valency platform molecules and biologically active molecules App 20020107389 - Coutts, Stephen M. ; et al.	2002-08-08
Conjugates of T cell epitope deficient immunogen analogs for humoral anergy and chemically defined non-polymeric valency platform molecules App 20020082400 - Coutts, Stephen M. ; et al.	2002-06-27
Composition for inducing humoral anergy to an immunogen comprising a T cell epitope-deficient analog of the immunogen conjugated to a nonimmunogenic valency platform molecule Grant 6,060,056 - Coutts , et al. May 9, 2	2000-05-09
Chemically-defined non-polymeric valency platform molecules and conjugates thereof Grant 5,606,047 - Coutts , et al. February 25, 1	1997-02-25
Chemically-defined non-polymeric valency platform molecules and conjugates thereof Grant 5,552,391 - Coutts , et al. September 3, 1	1996-09-03
1-Benzazepines and their pharmaceutical uses Grant 4,477,446 - Jones , et al. October 16, 1	1984-10-16

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.